TrialHaematologica2019

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.

Emanuela Messa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.